Clinical trials have explored the safety profile of AOD and reported few adverse effects, such as insulin resistance or unwanted muscle growth, which are typically associated with traditional GH therapies (2)
This page is research-only and provides no dosing, administration, clinical, diagnostic, therapeutic, veterinary, cosmetic-use, or human-use guidance
Peptides may retain only 70-85% potency
Is 250 mcg the same as 0.25 mg
For instance, some athletes use growth hormone-releasing peptides to help their body produce more growth hormone
Age-related cardiovascular changes add another layer of complexity